News
Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for longer. A team ...
Dr Stephen John Sammut, a clinician scientist at The Institute of Cancer Research, London, has been awarded one of the eight 2025 research prizes from the Lister Institute of Preventive Medicine.
The study found that cancer cells can develop a “memory”, through switching on and off certain processes in the cell, known as “epigenetic changes”. Cells can “remember” the form and appearance they ...
Scientists have discovered clues which may explain why some treatments stop working for people with bowel cancer – causing around 16,800 deaths in the UK every year. The study, led by researchers at ...
Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer. Research published in the journal Blood ...
News from ASCO 2025 From 30 May to 3 June, the world’s leading oncologists and researchers, including scientists from The Institute of Cancer Research, London, will converge at the 2025 American ...
ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...
ASCO 2025: Experts gather to showcase their ground-breaking cancer researchASCO 2025: Experts gather to showcase their ground-breaking cancer research From 30 May to 3 June, the world’s leading ...
A new frontier in cancer research: the rise of radiotheranostics Radiotheranostics is an exciting new field that has the potential to transform how cancers are detected and treated. Robbie Lockyer ...
ICR welcomes approval for new ovarian cancer drug combinationThe Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US ...
Scientists have worked out how a protective element of our DNA helps prevent an abnormal genetic event that can lead to cells becoming cancerous. They have shown exactly how telomeres – the protective ...
A recent study on an aggressive type of brain cancer has significantly advanced the understanding of the spectrum of tumours that occur in teenagers and young adults (TYA). High-grade gliomas (HGGs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results